1. Home
  2. CMCSA vs REGN Comparison

CMCSA vs REGN Comparison

Compare CMCSA & REGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMCSA
  • REGN
  • Stock Information
  • Founded
  • CMCSA 1963
  • REGN 1988
  • Country
  • CMCSA United States
  • REGN United States
  • Employees
  • CMCSA N/A
  • REGN N/A
  • Industry
  • CMCSA Cable & Other Pay Television Services
  • REGN Biotechnology: Pharmaceutical Preparations
  • Sector
  • CMCSA Telecommunications
  • REGN Health Care
  • Exchange
  • CMCSA Nasdaq
  • REGN Nasdaq
  • Market Cap
  • CMCSA 127.5B
  • REGN 63.4B
  • IPO Year
  • CMCSA 1972
  • REGN 1991
  • Fundamental
  • Price
  • CMCSA $34.22
  • REGN $547.67
  • Analyst Decision
  • CMCSA Buy
  • REGN Buy
  • Analyst Count
  • CMCSA 22
  • REGN 23
  • Target Price
  • CMCSA $43.84
  • REGN $907.39
  • AVG Volume (30 Days)
  • CMCSA 24.9M
  • REGN 1.2M
  • Earning Date
  • CMCSA 04-24-2025
  • REGN 04-29-2025
  • Dividend Yield
  • CMCSA 3.86%
  • REGN 0.32%
  • EPS Growth
  • CMCSA 7.84
  • REGN 16.49
  • EPS
  • CMCSA 4.07
  • REGN 39.43
  • Revenue
  • CMCSA $123,560,000,000.00
  • REGN $14,085,700,000.00
  • Revenue This Year
  • CMCSA $1.93
  • REGN $2.38
  • Revenue Next Year
  • CMCSA $3.09
  • REGN $7.65
  • P/E Ratio
  • CMCSA $8.42
  • REGN $14.23
  • Revenue Growth
  • CMCSA 1.33
  • REGN 7.52
  • 52 Week Low
  • CMCSA $31.44
  • REGN $520.50
  • 52 Week High
  • CMCSA $45.31
  • REGN $1,211.20
  • Technical
  • Relative Strength Index (RSI)
  • CMCSA 47.85
  • REGN 38.69
  • Support Level
  • CMCSA $33.98
  • REGN $542.44
  • Resistance Level
  • CMCSA $34.88
  • REGN $615.61
  • Average True Range (ATR)
  • CMCSA 0.74
  • REGN 22.06
  • MACD
  • CMCSA 0.13
  • REGN -0.13
  • Stochastic Oscillator
  • CMCSA 77.44
  • REGN 28.57

About CMCSA Comcast Corporation

Comcast is made up of three parts. The core cable business owns networks capable of providing television, internet access, and phone services to 63 million US homes and businesses, or nearly half of the country. About 50% of the locations in this territory subscribe to at least one Comcast service. Comcast acquired NBCUniversal from General Electric in 2011. NBCU owns several cable networks, including CNBC, MSNBC, and USA, the NBC network, the Peacock streaming platform, several local NBC affiliates, Universal Studios, and several theme parks. Sky, acquired in 2018, is a large television provider in the UK and has invested heavily in proprietary content to build this position. Sky is also a large pay-television provider in Italy and has a presence in Germany and Austria.

About REGN Regeneron Pharmaceuticals Inc.

Regeneron Pharmaceuticals Inc discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has earlier-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and Crispr-based gene editing (Intellia).

Share on Social Networks: